1.Development of the Attention-Deficit Hyperactivity Disorder-After School Checklist.
Hanik K YOO ; Hannah HUH ; Sukhyun LEE ; Kwangmo JUNG ; Bongseog KIM
Journal of the Korean Academy of Child and Adolescent Psychiatry 2018;29(2):47-53
OBJECTIVES: This study aimed to develop the attention-deficit hyperactivity disorder (ADHD)-After School Checklist (ASK) to evaluate the severity of ADHD symptoms and self-management ability in children and adolescents in South Korea. Additionally, we evaluated the reliability and validity of the scale. METHODS: We developed the ASK to evaluate the effect of ADHD psychopathologies on self-management and interpersonal impulsivity. We investigated the reliability and validity of the scale with 1349 parents (male 56.9%; 1202 parents of non-ADHD children, 147 parents of children with ADHD) in Seoul and Gyeonggi Province, Korea. RESULTS: According to the construct validity test using principal constant analysis with the varimax rotation method, two factors explained 60.7% of the cumulative variance in ASK scores. Cronbach's alpha for the whole scale was 0.71. There was no statistical difference between mean ASK scores at test and retest. Mean total ASK scores of the ADHD group were significantly higher than those of the non-ADHD group (p < 0.001). CONCLUSION: The ASK can be used as a reliable and valid tool to evaluate not only self-management capability of children and adolescents with ADHD in their academic and everyday life, but also their impulsiveness in interpersonal relationships.
Adolescent
;
Checklist*
;
Child
;
Gyeonggi-do
;
Humans
;
Impulsive Behavior
;
Korea
;
Mass Screening
;
Methods
;
Parents
;
Reproducibility of Results
;
Self Care
;
Seoul
2.Survey of Public Attitudes toward the Secondary Use of Public Healthcare Data in Korea
Junho JUNG ; Hyungjin KIM ; Seung-Hwa LEE ; Jungchan PARK ; Sungsoo LIM ; Kwangmo YANG
Healthcare Informatics Research 2023;29(4):377-385
Objectives:
Public healthcare data have become crucial to the advancement of medicine, and recent changes in legal structure on privacy protection have expanded access to these data with pseudonymization. Recent debates on public healthcare data use by private insurance companies have shown large discrepancies in perceptions among the general public, healthcare professionals, private companies, and lawmakers. This study examined public attitudes toward the secondary use of public data, focusing on differences between public and private entities.
Methods:
An online survey was conducted from January 11 to 24, 2022, involving a random sample of adults between 19 and 65 of age in 17 provinces, guided by the August 2021 census.
Results:
The final survey analysis included 1,370 participants. Most participants were aware of health data collection (72.5%) and recent changes in legal structures (61.4%) but were reluctant to share their pseudonymized raw data (51.8%). Overall, they were favorable toward data use by public agencies but disfavored use by private entities, notably marketing and private insurance companies. Concerns were frequently noted regarding commercial use of data and data breaches. Among the respondents, 50.9% were negative about the use of public healthcare data by private insurance companies, 22.9% favored this use, and 1.9% were “very positive.”
Conclusions
This survey revealed a low understanding among key stakeholders regarding digital health data use, which is hindering the realization of the full potential of public healthcare data. This survey provides a basis for future policy developments and advocacy for the secondary use of health data.
3.Clinical utilization of radiation therapy in Korea between 2017 and 2019
Eunji KIM ; Won Il JANG ; Kwangmo YANG ; Mi-Sook KIM ; Hyung Jun YOO ; Eun Kyung PAIK ; Heejin KIM ; Jaesun YOON ;
Radiation Oncology Journal 2022;40(4):251-259
Purpose:
This study aimed to evaluate the clinical infrastructure and utilization of radiotherapy (RT) services in Korea between 2017 and 2019.
Materials and Methods:
We extracted the data of patients who underwent RT between 2017 and 2019 from the Health Insurance Review and Assessment Service. We further analyzed this data according to the diagnosis and treatment modalities of patients diagnosed with International Classification of Disease 10 (ICD-10) diagnostic codes C00–C97 and D00–D48. In addition, we collected statistics on RT facilities in Korea using a nationwide survey.
Results:
The total number of patients who received RT in 2017, 2018, and 2019 were 77,901, 81,849, and 87,460, respectively. The number of patients diagnosed with ICD 10 C- and D-codes in 2019 was 86,339, of whom 39,467 were men and 46,872 women. The rate of utilization of RT among cancer patients was 30.4% in 2017 and 2018 and 30.9% in 2019. In 2019, the most common types of cancers treated with RT were breast, lung, prostate, colorectal, and liver cancers. Regarding the RT infrastructure in Korea, there were 95 radiation oncology centers, 237 megavoltage (MV) teletherapy units, 35 brachytherapy units, and two proton accelerators in 2019. There were 4.5 MV teletherapy machines per million.
Conclusion
The number of patients treated with RT has increased consistently from 2017 to 2019. As the number of patients with cancer increases, it is expected that the RT infrastructure will be further expanded in Korea.
4.Risk Determination for Localised Renal Cell Carcinomas under 4 cm or Less: A Multi-institutional Analysis.
Kwangmo KIM ; Sangchul LEE ; Sung Kyu HONG ; Cheol KWAK ; Yong June KIM ; Jinsoo CHUNG ; Seok Ho KANG ; Eu Chang HWANG ; Sung Hoo HONG ; Seok Soo BYUN
Korean Journal of Urological Oncology 2016;14(3):138-143
PURPOSE: To determine the malignant potential in clinically localised small renal cell carcinoma (RCC) (≤4cm) in patients using postoperative pathologic outcomes. MATERIALS AND METHODS: We performed a retrospective analysis of 2,085 patients in 7 urology centres with clinical T1a RCC who underwent nephrectomy. The pathologic upstaging group (PUG) was defined by pathologic T3a after the operation. Multivariate analyses were used to examine predicting factors for the risk of PUG. Next, Kaplan-Meier analysis was used to examine the PUG for worse recurrence-free survival during the follow-up period. RESULTS: The PUG had 73 patients (3.5%); they were older and had a larger tumour size than the other patients (all p<0.001). After adjusting for clinical characteristics, age (odds ratio [OR], 1.04; 95% confidence interval [CI], 1.02–1.06) and tumour size greater than 3 cm (OR, 1.94; 95% CI, 1.21–3.11) were found to be independent predictors for the PUG after nephrectomy. Furthermore, the PUG had worse recurrence-free survival during the follow-up period. CONCLUSIONS: In this multi-institution analysis, RCC 3 cm or greater in older patients had a high malignant potential compared to relatively small tumours in younger patients. These results may be helpful for stratifying patients to manage small renal masses.
Carcinoma, Renal Cell*
;
Follow-Up Studies
;
Humans
;
Kaplan-Meier Estimate
;
Multivariate Analysis
;
Nephrectomy
;
Retrospective Studies
;
Urology
5.Study on the Evaluation of TRS-398 Quality Factors with Central Electrode Corrections for Small Cylindrical Chambers.
Yeong Rok KANG ; Chang Yeol LEE ; Jin Ho KIM ; Young Min MOON ; Dong Won KWAK ; Sang Koo KANG ; Jeung Kee KIM ; Kwangmo YANG ; Dong Hyeok JEONG
Korean Journal of Medical Physics 2011;22(3):148-154
The quality factors (kQ,Q0) were evaluated by appling the results recently studied for the effect of central electrode in TRS-398 protocol. The PTW-31010 and IBA-CC13 chambers were used in this study. The quality factors were calculated as a function of beam quality for high energy electron and photon beams and compared with data currently used in TRS-398 protocol. In the PTW-31010 chamber using aluminium electrode, appling the new central electrode collections, the quality factors were 0.4% and 0.9% higher than current TRS-398 data for high energy photon and electron beams respectively. In the IBA-CC13 chamber using C-552 electrode, there are no variations in quality factors compared to TRS-398 data currently used.
Electrodes
;
Electrons
6.Mildly Elevated Cardiac Troponin below the 99th-Percentile Upper Reference Limit after Noncardiac Surgery
Jungchan PARK ; Cheol Won HYEON ; Seung-Hwa LEE ; Jihoon KIM ; Ji-Hye KWON ; Kwangmo YANG ; Jeong Jin MIN ; Jong Hwan LEE ; Sangmin Maria LEE ; Jeong Hoon YANG ; Young Bin SONG ; Joo-Yong HAHN ; Jin-ho CHOI ; Seung-Hyuk CHOI ; Kyunga KIM ; Joonghyun AHN ; Hyeon-Cheol GWON
Korean Circulation Journal 2020;50(10):925-937
Background and Objectives:
In patients with perioperative cardiac troponin (cTn) I below the 99th-percentile upper range of limit (URL), mortality according to cTn I level has not been fully evaluated. This study evaluated the association between postoperative cTn I level above the lowest limit of detection but within the 99th-percentile URL and 30-day mortality after noncardiac surgery.
Methods:
Patients with cTn I values below the 99th-percentile URL during the perioperative period were divided into a no-elevation group with cTn I at the lowest limit of detection (6 ng/L) and a minor elevation group with cTn I elevation below the 99th percentile URL (6 ng/L < cTn I < 40 ng/L). The primary outcome was 30-day mortality.
Results:
Of the 5,312 study participants, 2,582 (48.6%) were included in the no-elevation group and 2,730 (51.4%) were included in the minor elevation group. After propensity scorematching, the minor elevation group showed significantly increased 30-day mortality (0.5% vs. 2.3%; hazard ratio, 4.30; 95% confidence interval, 2.23–8.29; p<0.001). The estimated cutoff value of cTn I to predict 30-day mortality was 6 ng/L with the area under the receiver operating characteristic curve 0.657.
Conclusions
A mild elevation of cTn I within the 99th-percentile URL after noncardiac surgery was significantly associated with increased 30-day mortality as compared with the lowest limit of detection.